Taiwan · Delayed Price · Currency is TWD Sinphar Pharmaceutical Statistics
Total Valuation
TPE:1734 has a market cap or net worth of TWD 6.47 billion. The enterprise value is 7.20 billion.
| Market Cap | 6.47B |
| Enterprise Value | 7.20B |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | Jul 24, 2026 |
Share Statistics
TPE:1734 has 201.61 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 201.61M |
| Shares Outstanding | 201.61M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 9.62% |
| Owned by Institutions (%) | 2.95% |
| Float | 141.63M |
Valuation Ratios
The trailing PE ratio is 18.49.
| PE Ratio | 18.49 |
| Forward PE | n/a |
| PS Ratio | 1.88 |
| PB Ratio | 1.74 |
| P/TBV Ratio | 1.91 |
| P/FCF Ratio | 19.50 |
| P/OCF Ratio | 10.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.98, with an EV/FCF ratio of 21.68.
| EV / Earnings | 20.46 |
| EV / Sales | 2.09 |
| EV / EBITDA | 10.98 |
| EV / EBIT | 17.53 |
| EV / FCF | 21.68 |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.55.
| Current Ratio | 2.04 |
| Quick Ratio | 1.48 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 6.17 |
| Interest Coverage | 12.12 |
Financial Efficiency
Return on equity (ROE) is 9.42% and return on invested capital (ROIC) is 8.07%.
| Return on Equity (ROE) | 9.42% |
| Return on Assets (ROA) | 3.96% |
| Return on Invested Capital (ROIC) | 8.07% |
| Return on Capital Employed (ROCE) | 7.77% |
| Weighted Average Cost of Capital (WACC) | 3.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.32 |
Taxes
In the past 12 months, TPE:1734 has paid 68.04 million in taxes.
| Income Tax | 68.04M |
| Effective Tax Rate | 16.74% |
Stock Price Statistics
The stock price has increased by +11.38% in the last 52 weeks. The beta is 0.09, so TPE:1734's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | +11.38% |
| 50-Day Moving Average | 30.64 |
| 200-Day Moving Average | 29.73 |
| Relative Strength Index (RSI) | 66.58 |
| Average Volume (20 Days) | 196,067 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:1734 had revenue of TWD 3.45 billion and earned 351.67 million in profits. Earnings per share was 1.74.
| Revenue | 3.45B |
| Gross Profit | 1.54B |
| Operating Income | 410.47M |
| Pretax Income | 406.36M |
| Net Income | 351.67M |
| EBITDA | 653.96M |
| EBIT | 410.47M |
| Earnings Per Share (EPS) | 1.74 |
Balance Sheet
The company has 1.59 billion in cash and 2.05 billion in debt, with a net cash position of -451.57 million or -2.24 per share.
| Cash & Cash Equivalents | 1.59B |
| Total Debt | 2.05B |
| Net Cash | -451.57M |
| Net Cash Per Share | -2.24 |
| Equity (Book Value) | 3.72B |
| Book Value Per Share | 17.11 |
| Working Capital | 1.63B |
Cash Flow
In the last 12 months, operating cash flow was 598.31 million and capital expenditures -266.51 million, giving a free cash flow of 331.81 million.
| Operating Cash Flow | 598.31M |
| Capital Expenditures | -266.51M |
| Depreciation & Amortization | 243.49M |
| Net Borrowing | 377.37M |
| Free Cash Flow | 331.81M |
| FCF Per Share | 1.65 |
Margins
Gross margin is 44.58%, with operating and profit margins of 11.90% and 10.19%.
| Gross Margin | 44.58% |
| Operating Margin | 11.90% |
| Pretax Margin | 11.78% |
| Profit Margin | 10.19% |
| EBITDA Margin | 18.95% |
| EBIT Margin | 11.90% |
| FCF Margin | 9.62% |
Dividends & Yields
This stock pays an annual dividend of 0.94, which amounts to a dividend yield of 2.94%.
| Dividend Per Share | 0.94 |
| Dividend Yield | 2.94% |
| Dividend Growth (YoY) | 5.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 51.51% |
| FCF Payout Ratio | 57.32% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 2.90% |
| Earnings Yield | 5.43% |
| FCF Yield | 5.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 27, 2026. It was a forward split with a ratio of 1.06.
| Last Split Date | Aug 27, 2026 |
| Split Type | Forward |
| Split Ratio | 1.06 |
Scores
TPE:1734 has an Altman Z-Score of 2.24 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.24 |
| Piotroski F-Score | 6 |